Tanya Simuni

16.3k total citations · 2 hit papers
162 papers, 5.6k citations indexed

About

Tanya Simuni is a scholar working on Neurology, Cognitive Neuroscience and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tanya Simuni has authored 162 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Neurology, 35 papers in Cognitive Neuroscience and 24 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tanya Simuni's work include Parkinson's Disease Mechanisms and Treatments (122 papers), Neurological disorders and treatments (73 papers) and Autism Spectrum Disorder Research (20 papers). Tanya Simuni is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (122 papers), Neurological disorders and treatments (73 papers) and Autism Spectrum Disorder Research (20 papers). Tanya Simuni collaborates with scholars based in United States, Canada and United Kingdom. Tanya Simuni's co-authors include Chelsea Caspell‐Garcia, Lana M. Chahine, Andrew Siderowf, Colum D. MacKinnon, Cindy Zadikoff, Kenneth Marek, Amy Colcher, Aleksandar Videnović, Christopher S. Coffey and Shirley Lasch and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tanya Simuni

159 papers receiving 5.5k citations

Hit Papers

Progress towards therapies for disease modification in Pa... 2021 2026 2022 2024 2021 2024 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Progress towards therapies for disease modification in Parkinson's disease
    2021 252 citations Tanya Simuni et al. profile →
  2. Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s disease
    2024 56 citations Gennaro Pagano, Tanya Simuni et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tanya Simuni United States 43 3.8k 1.1k 1.0k 734 709 162 5.6k
Martijn L.T.M. Müller United States 38 3.1k 0.8× 1.2k 1.0× 1.2k 1.2× 627 0.9× 614 0.9× 111 4.9k
Alison J. Yarnall United Kingdom 40 3.6k 0.9× 780 0.7× 916 0.9× 1.1k 1.5× 768 1.1× 111 5.5k
Piu Chan China 42 2.9k 0.8× 1.1k 1.0× 954 0.9× 447 0.6× 865 1.2× 128 5.0k
Regina Katzenschlager Austria 40 5.7k 1.5× 1.8k 1.6× 1.1k 1.1× 771 1.1× 427 0.6× 71 7.4k
Marianna Amboni Italy 43 4.0k 1.0× 769 0.7× 1.4k 1.4× 922 1.3× 390 0.6× 131 5.7k
Claudio Pacchetti Italy 41 3.4k 0.9× 1.1k 1.0× 995 1.0× 517 0.7× 561 0.8× 135 4.8k
Caroline Rick United Kingdom 25 4.4k 1.2× 1.9k 1.7× 1.2k 1.2× 814 1.1× 588 0.8× 54 6.5k
Santiago Perez‐Lloret Argentina 36 3.1k 0.8× 1.0k 0.9× 788 0.8× 616 0.8× 429 0.6× 131 4.9k
Carmine Vitale Italy 46 4.0k 1.1× 775 0.7× 1.6k 1.6× 891 1.2× 357 0.5× 137 5.5k
Elan D. Louis United States 49 4.1k 1.1× 1.5k 1.3× 909 0.9× 1.1k 1.5× 1.1k 1.5× 135 6.9k

Countries citing papers authored by Tanya Simuni

Since Specialization
Citations

This map shows the geographic impact of Tanya Simuni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanya Simuni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanya Simuni more than expected).

Fields of papers citing papers by Tanya Simuni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanya Simuni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanya Simuni. The network helps show where Tanya Simuni may publish in the future.

Co-authorship network of co-authors of Tanya Simuni

This figure shows the co-authorship network connecting the top 25 collaborators of Tanya Simuni. A scholar is included among the top collaborators of Tanya Simuni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanya Simuni. Tanya Simuni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Postuma, Ronald B., Tanya Simuni, Mayela Rodríguez‐Violante, et al.. (2024). Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome. Movement Disorders Clinical Practice. 11(8). 983–991. 3 indexed citations
2.
Pagano, Gennaro, Annabelle Monnet, Benjamin Ribba, et al.. (2024). Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial. Nature Medicine. 30(12). 3669–3675. 14 indexed citations
3.
Marras, Connie, Seyed‐Mohammad Fereshtehnejad, Daniela Berg, et al.. (2024). Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach. Movement Disorders. 39(3). 462–471. 21 indexed citations
4.
Merchant, Kalpana, Tanya Simuni, Chelsea Caspell‐Garcia, et al.. (2023). LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts. npj Parkinson s Disease. 9(1). 30–30. 12 indexed citations
5.
Brumm, Michael C., Andrew Siderowf, Tanya Simuni, et al.. (2023). Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression. Journal of Parkinson s Disease. 13(6). 899–916. 25 indexed citations
6.
Chahine, Lana M., Kalpana Merchant, Andrew Siderowf, et al.. (2023). Proposal for a Biologic Staging System of Parkinson’s Disease. Journal of Parkinson s Disease. 13(3). 297–309. 45 indexed citations
7.
Marebwa, Barbara, Tanya Simuni, Andrew Siderowf, et al.. (2022). Deep Learning for Daily Monitoring of Parkinson’s Disease Outside the Clinic Using Wearable Sensors. Sensors. 22(18). 6831–6831. 13 indexed citations
8.
Alcalay, Roy N., Pavlina Wolf, Ming Sum Ruby Chiang, et al.. (2020). Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients. Annals of Clinical and Translational Neurology. 7(10). 1816–1830. 25 indexed citations
9.
10.
11.
Sokol, Leonard L., Michael J. Young, Benzi M. Kluger, et al.. (2019). Advance care planning in Parkinson’s disease: ethical challenges and future directions. npj Parkinson s Disease. 5(1). 24–24. 35 indexed citations
12.
Fischer, Tanya, Thomas Gasser, Stuart Isaacson, et al.. (2019). Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson’s disease patients with a GBA mutation (S4.002). Neurology. 92(15_supplement). 3 indexed citations
13.
McFarthing, Kevin, et al.. (2019). CLINICAL TRIAL HIGHLIGHTS – DYSKINESIA. Journal of Parkinson s Disease. 9(3). 449–465. 12 indexed citations
14.
Sardi, S. Pablo & Tanya Simuni. (2018). New Era in disease modification in Parkinson's disease: Review of genetically targeted therapeutics. Parkinsonism & Related Disorders. 59. 32–38. 20 indexed citations
15.
16.
Bega, Danny, Paulina González-Latapí, Cindy Zadikoff, & Tanya Simuni. (2014). A Review of the Clinical Evidence for Complementary and Alternative Therapies in Parkinson’s Disease. Current Treatment Options in Neurology. 16(10). 314–314. 48 indexed citations
17.
Stegemöller, Elizabeth L., David P. Allen, Tanya Simuni, & Colum D. MacKinnon. (2010). Rate-dependent impairments in repetitive finger movements in patients with Parkinson's disease are not due to peripheral fatigue. Neuroscience Letters. 482(1). 1–6. 20 indexed citations
18.
Page, David B., Frances M. Weaver, Diana J. Wilkie, & Tanya Simuni. (2009). A computerized survey of pain in Parkinson's disease patients: A pilot feasibility study. Parkinsonism & Related Disorders. 16(2). 139–141. 13 indexed citations
19.
Liang, Grace, Kelvin L. Chou, Gordon H. Baltuch, et al.. (2006). Long-Term Outcomes of Bilateral Subthalamic Nucleus Stimulation in Patients with Advanced Parkinson’s Disease. Stereotactic and Functional Neurosurgery. 84(5-6). 221–227. 69 indexed citations
20.
Simuni, Tanya, Jurg L. Jaggi, Howard I. Hurtig, et al.. (2002). Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. Journal of neurosurgery. 96(4). 666–672. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martijn L.T.M. Müller Breakdown of academic impact, for papers by Alison J. Yarnall Breakdown of academic impact, for papers by Piu Chan Breakdown of academic impact, for papers by Regina Katzenschlager Breakdown of academic impact, for papers by Marianna Amboni Breakdown of academic impact, for papers by Claudio Pacchetti Breakdown of academic impact, for papers by Caroline Rick Breakdown of academic impact, for papers by Santiago Perez‐Lloret Breakdown of academic impact, for papers by Carmine Vitale Breakdown of academic impact, for papers by Elan D. Louis
Rankless by CCL
2026